InnovAge Holding Corp. (INNV) reported a balance sheet as of March 31, 2026 with total assets of $547.4M against total liabilities of $288.5M, producing GAAP book equity of $232.8M (including noncontrolling interests). Under liquidation-value methodology, recovery to equity is materially negative, consistent with MFFAIS-computed CLV/LLV of approximately -$153M to -$182M. The asset side haircut is severe: goodwill of $142.0M carries zero liquidation value; intangibles net of $3.4M similarly zero. PP&E gross of $275.0M with accumulated depreciation of $109.7M yields net book of $165.4M, of which $10.0M is finance lease ROU assets — applying a 50-60% recovery to tangible PP&E yields roughly $83-99M. Cash/equivalents of $95.5M recover at par; short-term investments (mutual funds) of $43.1M at par or near-par; net AR of $28.6M at 90-95% haircut yields $25.7-27.2M. Operating lease ROU assets of $23.7M receive zero recovery in liquidation. The liability stack at face value is the driver of negative recovery: accounts payable and accrued liabilities of $105.6M, a $34.4M litigation accrual (current), total debt of $58.8M gross ($49.4M Term Loan A + $9.4M revolver draw), operating lease liabilities of $25.3M (undiscounted $31.7M remaining obligations that do not extinguish), finance lease liabilities of $10.6M (undiscounted $12.3M), deferred tax liabilities net of $9.3M, and redeemable noncontrolling interest of $26.1M (redemption obligation that sits ahead of common equity). The single most material change versus the prior filing (December 31, 2025) is the $34.4M litigation accrual now tagged under LossContingencyAccrualCarryingValueCurrent — this represents a step-change in the liability stack, driven by a $35.5M net increase in litigation expenses recognized in Q3 FY2026 corporate G&A. Total G&A for the nine-month period reached $133.4M vs. $94.2M in the comparable prior-year period, with Q3 alone at $76.5M vs. $38.6M in Q3 FY2025 — nearly all of the Q3 increment attributable to litigation accruals. The Adjusted EBITDA addback for litigation costs and settlements was $54.1M for the nine months ended March 31, 2026. The litigation accrual does not extinguish in a wind-up scenario. Debt outstanding declined marginally from $59.4M at December 31, 2025 to $58.8M at March 31, 2026 on scheduled amortization. Operating lease undiscounted obligations declined from $33.3M to $31.7M as leases roll. The OBBBA-related Medicaid rate pressure and California PACE moratorium are balance-sheet-neutral in this period but represent contingent structural headwinds to the revenue base underpinning any enterprise value. Net cash from operations was $43.4M for the nine-month period, a positive but insufficient offset to the permanent liability accruals. Filing discusses the $34.4M litigation accrual in MD&A and Note 9 but the specific contingency quantum is only XBRL-tagged at the current-period aggregate level; granular per-matter exposure is not separately tagged.
▼ Community Notes